会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BIS-(HYDROXYALKYLAMINO)-ANTHRAQUINONE INHIBITORS OF PROTEIN KINASE C
    • 蛋白激酶C(BIS-(羟基喹啉)) - 氨基丁酸酯抑制剂
    • WO1992007557A1
    • 1992-05-14
    • PCT/US1991008026
    • 1991-10-30
    • SPINX PHARMACEUTICALS CORPORATIONJIANG, Jack, B.JOHNSON, Mary, George
    • SPINX PHARMACEUTICALS CORPORATION
    • A61K31/045
    • C07D303/36C07C225/34C07C225/36C07C229/74C07C271/12C07C335/32C07C2603/24
    • The present invention provides novel substituted anthraquinones having formula ( alpha ), wherein R1 and R2 are independently H, C1-C10 alkyl, aryl, arylalkyl, alkylaryl, or R1 and R2 taken together with the adjacent nitrogen atom N form a substituted or unsubstituted cyclic ring which may contain additional heteroatoms; n and m are independently 1, 2, or 3; A is halogen, OH, alkoxy, OCO(NR3R4), S-C(NH2)=NR5, or when m = 1, comprises an oxirane ring with the adjacent oxygen atom; R3, R4, and R5 are independently H, alkyl, or aryl; X is H, OH, NR6R7, Cl, Br, I, F, alkyl, aryl, alkoxy, aryloxy, COOR8, or CONR9R10; and R6, R7, R8, R9, and R10 are independently H, lower alkyl, or aryl useful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
    • 本发明提供具有式(α)的新的取代的蒽醌,其中R 1和R 2独立地为H,C 1 -C 10烷基,芳基,芳基烷基,烷基芳基或R 1和R 2与相邻的氮原子N一起形成取代或未取代的环状 可能含有其他杂原子的环; n和m独立地为1,2或3; A是卤素,OH,烷氧基,OCO(NR 3 R 4),S-C(NH 2)= NR 5,或当m = 1时,包含具有相邻氧原子的环氧乙烷环; R3,R4和R5独立地是H,烷基或芳基; X是H,OH,NR 6 R 7,Cl,Br,I,F,烷基,芳基,烷氧基,芳氧基,COOR 8或CONR 9 R 10; R 6,R 7,R 8,R 9和R 10独立地为可用于抑制蛋白激酶C的H,低级烷基或芳基,并且与抑制蛋白激酶C,特别是癌症肿瘤,炎性疾病,再灌注损伤有关或受其影响 ,以及与再灌注损伤相关的心脏功能障碍。